Genome editing : the next step in gene therapy /

Saved in:
Bibliographic Details
Imprint:New York, NY : Springer, 2016.
Description:1 online resource (xvi, 263 pages) : illustrations (some color)
Language:English
Series:Advances in experimental medicine and biology, 0065-2598 ; volume 895
Advances in experimental medicine and biology ; v. 895.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11253408
Hidden Bibliographic Details
Other authors / contributors:Cathomen, Toni, editor.
Hirsch, Matthew, editor.
Porteus, Matthew H., editor.
ISBN:9781493935093
1493935097
1493935070
9781493935079
9781493935086
1493935089
9781493980611
1493980610
9781493935079
Digital file characteristics:text file PDF
Notes:Includes index.
English.
Online resource; title from PDF title page (SpringerLink, viewed March 7, 2016).
Summary:This comprehensive volume explores human genetic engineering its pre-clinical and clinical applications, current developments, and as treatment for hereditary diseases. It presents and evaluates the most recent advances in the understanding of mammalian host DNA repair mechanisms, such as double-strand break induced gene targeting and mutagenesis, the development of zinc-finger nucleases, genome editing for neuromuscular diseases, phase integrases, triplex forming oligonucleotides and peptide nucleic acids, aptamer-guided gene targeting, AAV gene editing via DSB repair, engineered nucleases and trinucleotide repeat diseases, and creation of HIV-resistant cells. The expertly authored chapters contextualize current developments within the history of genome editing while also discussing the current and potential safety concerns of this rapidly growing field. Genome Editing: The Next Step in Gene Therapy, the latest volume in the American Society of Gene and Cell Therapy series, deftly illuminates the potential of genetic engineering technology to eradicate today's deadliest and most prolific diseases. It is ideal reading for clinicians and researchers in genetics and immunology.
Other form:Printed edition: 9781493935079
Standard no.:10.1007/978-1-4939-3509-3

MARC

LEADER 00000cam a2200000Ii 4500
001 11253408
005 20210625184005.7
006 m o d
007 cr cnu|||unuuu
008 160307s2016 nyua o 001 0 eng d
015 |a GBB8M4838  |2 bnb 
016 7 |a 019140376  |2 Uk 
019 |a 981047176  |a 988789408  |a 1005793982  |a 1012053081  |a 1048167070  |a 1066626835  |a 1103254367  |a 1110967740  |a 1112589448  |a 1112878267  |a 1113746873  |a 1117079302  |a 1122845727  |a 1127162166 
020 |a 9781493935093  |q (electronic bk.) 
020 |a 1493935097  |q (electronic bk.) 
020 |a 1493935070  |q (print) 
020 |a 9781493935079  |q (print) 
020 |a 9781493935086  |q (print) 
020 |a 1493935089 
020 |a 9781493980611  |q (print) 
020 |a 1493980610 
020 |z 9781493935079 
024 7 |a 10.1007/978-1-4939-3509-3  |2 doi 
035 |a (OCoLC)944031720  |z (OCoLC)981047176  |z (OCoLC)988789408  |z (OCoLC)1005793982  |z (OCoLC)1012053081  |z (OCoLC)1048167070  |z (OCoLC)1066626835  |z (OCoLC)1103254367  |z (OCoLC)1110967740  |z (OCoLC)1112589448  |z (OCoLC)1112878267  |z (OCoLC)1113746873  |z (OCoLC)1117079302  |z (OCoLC)1122845727  |z (OCoLC)1127162166 
035 9 |a (OCLCCM-CC)944031720 
037 |a com.springer.onix.9781493935093  |b Springer Nature 
040 |a GW5XE  |b eng  |e rda  |e pn  |c GW5XE  |d N$T  |d YDXCP  |d IDEBK  |d EBLCP  |d AZU  |d OCLCF  |d COO  |d UAB  |d JG0  |d OCLCQ  |d VT2  |d IAD  |d JBG  |d ICW  |d Z5A  |d ILO  |d UPM  |d ICN  |d OCLCQ  |d ESU  |d IOG  |d U3W  |d BUF  |d OCLCQ  |d WYU  |d OCLCO  |d OCLCA  |d MERER  |d OCLCO  |d UKMGB  |d UKAHL  |d OCLCQ  |d OCLCO  |d DCT  |d ERF  |d UKBTH  |d LEATE  |d OCLCQ  |d OCLCA  |d AJS 
049 |a MAIN 
050 4 |a QH442 
060 4 |a QT 36 
072 7 |a MFN  |2 bicssc 
072 7 |a MED107000  |2 bisacsh 
072 7 |a SCI  |x 013060  |2 bisacsh 
072 7 |a TEC  |x 009010  |2 bisacsh 
072 7 |a MFN  |2 thema 
245 0 0 |a Genome editing :  |b the next step in gene therapy /  |c Toni Cathomen, Matthew Hirsch, Matthew Porteus, editors. 
264 1 |a New York, NY :  |b Springer,  |c 2016. 
300 |a 1 online resource (xvi, 263 pages) :  |b illustrations (some color) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in experimental medicine and biology,  |x 0065-2598 ;  |v volume 895 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed March 7, 2016). 
505 0 |a 1. Gene Editing: Double-Strand Break Induced Gene Targeting and Mutagenesis 20 Years Later -- 2. The Development and Use of Zinc-Finger Nucleases -- 3. The Use and Development of TAL Effector Nucleases -- 4. Genome Editing for Neuromuscular Diseases -- 5. Phage Integrases for Genome Editing -- 6. Precise Genome Modification Using Triplex Forming Oligonucleotides and Peptide Nucleic Acids -- 7. Genome Editing by Aptamer-Guided Gene Targeting -- 8. Stimulation of AAV Gene Editing via DSB Repair -- 9. Engineered Nucleases and Trinucleotide Repeat Diseases -- 10. Using Engineered Nucleases to Create HIV-Resistant Cells -- 11. Strategies to Determine Off-Target Effects of Engineered Nucleases. 
520 |a This comprehensive volume explores human genetic engineering its pre-clinical and clinical applications, current developments, and as treatment for hereditary diseases. It presents and evaluates the most recent advances in the understanding of mammalian host DNA repair mechanisms, such as double-strand break induced gene targeting and mutagenesis, the development of zinc-finger nucleases, genome editing for neuromuscular diseases, phase integrases, triplex forming oligonucleotides and peptide nucleic acids, aptamer-guided gene targeting, AAV gene editing via DSB repair, engineered nucleases and trinucleotide repeat diseases, and creation of HIV-resistant cells. The expertly authored chapters contextualize current developments within the history of genome editing while also discussing the current and potential safety concerns of this rapidly growing field. Genome Editing: The Next Step in Gene Therapy, the latest volume in the American Society of Gene and Cell Therapy series, deftly illuminates the potential of genetic engineering technology to eradicate today's deadliest and most prolific diseases. It is ideal reading for clinicians and researchers in genetics and immunology. 
546 |a English. 
650 0 |a Genetic engineering.  |0 http://id.loc.gov/authorities/subjects/sh85053855 
650 0 |a Gene therapy.  |0 http://id.loc.gov/authorities/subjects/sh85053738 
650 2 |a Bioengineering. 
650 2 |a Genetic Therapy. 
650 7 |a Medical genetics.  |2 bicssc 
650 7 |a SCIENCE  |x Chemistry  |x Industrial & Technical.  |2 bisacsh 
650 7 |a TECHNOLOGY & ENGINEERING  |x Chemical & Biochemical.  |2 bisacsh 
650 7 |a Gene therapy.  |2 fast  |0 (OCoLC)fst00939638 
650 7 |a Genetic engineering.  |2 fast  |0 (OCoLC)fst00940027 
655 0 |a Electronic books. 
655 4 |a Electronic books. 
700 1 |a Cathomen, Toni,  |e editor. 
700 1 |a Hirsch, Matthew,  |e editor. 
700 1 |a Porteus, Matthew H.,  |e editor.  |0 http://id.loc.gov/authorities/names/no2015079043 
776 0 8 |i Printed edition:  |z 9781493935079 
830 0 |a Advances in experimental medicine and biology ;  |v v. 895.  |0 http://id.loc.gov/authorities/names/n42001229 
903 |a HeVa 
929 |a oclccm 
999 f f |i 1a791a04-6365-5714-9bb1-ccb327a8e755  |s d37a562c-8e82-5813-a221-0416f7946a2f 
928 |t Library of Congress classification  |a QH442  |l Online  |c UC-FullText  |u https://link.springer.com/10.1007/978-1-4939-3509-3  |z Springer Nature  |g ebooks  |i 12535396